{
  "id": 1643,
  "text": "98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "氢氧化尿素联合顺铂和5-氟尿嘧啶的序贯治疗相比单用氢氧化尿素在5年无病生存率（DFS）方面具有一定优势。根据研究，联合治疗显示出更低的风险比（OR = 0.65，95% CI = 0.45-0.94），这表明联合用药方案可能更有效地延长患者的无病生存时间。然而，需根据患者的个体情况及治疗耐受性综合评估。",
  "query": "如氢氧化尿素单药和联合顺铂、5-氟尿嘧啶加氢氧化尿素的治疗方案相比，在5年无病生存率（DFS）方面是否具有优势？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 如氢氧化尿素单药和联合顺铂、5-氟尿嘧啶加氢氧化尿素的治疗方案相比，在5年无病生存率（DFS）方面是否具有优势？\n\n<reference text>: 98 (95% CI = 0.70-1.38)</td></tr><tr><td>Rose et al.1437</td><td>2007</td><td>CCRT (hydroxyurea)</td><td>CCRT (cisplatin + 5 fluorouracil + hydroxyurea)</td><td>OR = 0.65 (95% CI= 0.45-0.94)</td></tr><tr><td> 5-year DFS rate</td><td></td><td></td><td></td><td></td></tr><tr><td>Zuliani et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "氢氧化尿素联合顺铂和5-氟尿嘧啶的序贯治疗相比单用氢氧化尿素在5年无病生存率（DFS）方面具有一定优势。根据研究，联合治疗显示出更低的风险比（OR = 0.65，95% CI = 0.45-0.94），这表明联合用药方案可能更有效地延长患者的无病生存时间。然而，需根据患者的个体情况及治疗耐受性综合评估。"
}